Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Merck, Seagen Drug Combo Seen as New Bladder Cancer Standard

<< Previous

Bullboard Posts

Next >>

Comment by Eoganachton Oct 23, 2023 5:22pm

159 Views

Post# 35697147

RE:Merck, Seagen Drug Combo Seen as New Bladder Cancer Standard

This treatment is for locallyadvanced bladder cancer where the cancer has spread to surrounding organs and muscles and metastatic urothelial cancer where it has spread to other parts of the body. They're just trying to improve overall survival and progression free survival rates.

reconsider wrote:
If we keep pushing deadlines we may lose the train

https://www.bloomberg.com/news/articles/2023-10-22/merck-seagen-drug-cocktail-seen-as-new-bladder-cancer-standard